CREB1 and type 2 diabetes mellitus: Interestingly, canonical pathways that were inhibited in T2D-HAMs (vs no-T2D-HAMs) at 2h, include ‘G-protein coupled receptor signaling’, ‘phagosome formation’, ‘focal adhesion kinase (FAK) signaling’ and ‘CREB signaling’.